Dear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
See More
Dear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
See MoreDear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
This page has been recently translated and is available in French now.
Looks like you're visiting us from {countryName}.
Would you like to stay on the current location site or be switched to your location?
Two-color flow cytometric analysis of TCR Cβ1 expression on Human peripheral blood T lymphocytes. Human peripheral blood cells were stained with BD Horizon™ BV421 Mouse Anti-Human CD3 (Cat. No. 562426; Left Plots), Alexa Fluor™ 488 Mouse Anti-Human CD4 (Cat. No, 557695; Center Plots), or BD Horizon™ BUV395 Mouse Anti-Human CD8 (Cat. No. 563795; Right Plots) antibodies and with either BD Horizon™ RY610 Mouse IgG2a, κ Isotype Control (Cat. No. 571157; Upper Plots) or BD Horizon™ RY610 Mouse Anti-Human TCR Cβ1 antibody (Cat. No. 571263/571323; Lower Plots) as indicated. The erythrocytes were lysed with BD FACS™ Lysing Solution (Cat. No. 349202). The bivariate pseudocolor density plots showing the correlated expression of TCR Cβ1 (or Ig Isotype control staining) versus CD3, CD4, or CD8 were derived from gated events with the forward and side light-scatter characteristics of intact Human lymphocytes. Flow cytometry and data analysis were performed using a BD LSRFortessa™ X-20 Cell Analyzer System and FlowJo™ Software.
Two-color flow cytometric analysis of TCR Cβ1 expression on Human peripheral blood T lymphocytes. Human peripheral blood cells were stained with BD Horizon™ BV421 Mouse Anti-Human CD3 (Cat. No. 562426; Left Plots), Alexa Fluor™ 488 Mouse Anti-Human CD4 (Cat. No, 557695; Center Plots), or BD Horizon™ BUV395 Mouse Anti-Human CD8 (Cat. No. 563795; Right Plots) antibodies and with either BD Horizon™ RY610 Mouse IgG2a, κ Isotype Control (Cat. No. 571157; Upper Plots) or BD Horizon™ RY610 Mouse Anti-Human TCR Cβ1 antibody (Cat. No. 571263/571323; Lower Plots) as indicated. The erythrocytes were lysed with BD FACS™ Lysing Solution (Cat. No. 349202). The bivariate pseudocolor density plots showing the correlated expression of TCR Cβ1 (or Ig Isotype control staining) versus CD3, CD4, or CD8 were derived from gated events with the forward and side light-scatter characteristics of intact Human lymphocytes. Flow cytometry and data analysis were performed using a BD LSRFortessa™ X-20 Cell Analyzer System and FlowJo™ Software.
Two-color flow cytometric analysis of TCR Cβ1 expression on Human peripheral blood T lymphocytes. Human peripheral blood cells were stained with BD Horizon™ BV421 Mouse Anti-Human CD3 (Cat. No. 562426; Left Plots), Alexa Fluor™ 488 Mouse Anti-Human CD4 (Cat. No, 557695; Center Plots), or BD Horizon™ BUV395 Mouse Anti-Human CD8 (Cat. No. 563795; Right Plots) antibodies and with either BD Horizon™ RY610 Mouse IgG2a, κ Isotype Control (Cat. No. 571157; Upper Plots) or BD Horizon™ RY610 Mouse Anti-Human TCR Cβ1 antibody (Cat. No. 571263/571323; Lower Plots) as indicated. The erythrocytes were lysed with BD FACS™ Lysing Solution (Cat. No. 349202). The bivariate pseudocolor density plots showing the correlated expression of TCR Cβ1 (or Ig Isotype control staining) versus CD3, CD4, or CD8 were derived from gated events with the forward and side light-scatter characteristics of intact Human lymphocytes. Flow cytometry and data analysis were performed using a BD LSRFortessa™ X-20 Cell Analyzer System and FlowJo™ Software.
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
BD® CompBeads can be used as surrogates to assess fluorescence spillover (compensation). When fluorochrome conjugated antibodies are bound to BD® CompBeads, they have spectral properties very similar to cells. However, for some fluorochromes there can be small differences in spectral emissions compared to cells, resulting in spillover values that differ when compared to biological controls. It is strongly recommended that when using a reagent for the first time, users compare the spillover on cells and BD® CompBeads to ensure that BD® CompBeads are appropriate for your specific cellular application.
The JOVI.1 monoclonal antibody recognizes an epitope common to a large proportion of human CD4+ or CD8+ T lymphocytes that express the T cell receptor beta chain (TCRβ). The antibody was generated from a mouse immunized with transgenic mouse lymphoid cells that expressed the rearranged human Vβ3-Cβ1 TCR chain derived from the cloned human HA1.7 T helper cell. This antibody reacts with TCR-Cβ1+ T cells and one of several different TCRβ V regions, but not with TCR-Cβ2+ T cells. JOV1.1 antibody reportedly recognized several Cβ1 TCR expressing cell lines or clones including Jurkat, CH7C17, and HA1.7 cells. The JOVI.1 antibody can be used to stimulate proliferative responses by JOVI.1-positive T cells. It can also reportedly be used for immunoprecipitation and to stain JOVI.1+ T cells in frozen tissue sections.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.